Mawson Infrastructure
MIGI
Bitdeer Technologies
BTDR
MARA Holdings
MARA
BTCS Inc
BTCS
Abits
ABTS
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.